Breaking News
Get 40% Off 0
Is NVDA a 🟢 buy or 🔴 sell? Unlock Now

5 Russell 2000 Stocks Poised to Give the Large Caps a Run for Their Money

By Investing.com (Ismael De La Cruz)Stock MarketsFeb 06, 2024 12:03
uk.investing.com/analysis/5-russell-2000-stocks-poised-to-give-the-large-caps-a-run-for-their-money-200599858
5 Russell 2000 Stocks Poised to Give the Large Caps a Run for Their Money
By Investing.com (Ismael De La Cruz)   |  Feb 06, 2024 12:03
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
 
US2000
+0.96%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
KPTI
-6.61%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
SP600
+0.29%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
VOR
-1.00%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
RLYB
+1.67%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
TNYA
0.00%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
  • While major US stock indexes focus on large-cap companies, the Russell 2000 offers insight into the health of small-cap businesses.
  • The Russell 2000 is significant as it comprises small companies that provide a unique perspective on the nation's economic well-being.
  • In this piece, we will examine five highly rated stocks within the Russell 2000.
  • In 2024, invest like the big funds from the comfort of your home with our AI-powered ProPicks stock selection tool. Learn more here>>

The three main stock market indexes in the country, the S&P 500, Dow Jones Industrial Average, and Nasdaq, primarily include large-cap companies. However, there are also other indexes composed of small-cap companies, such as the S&P 600 and the Russell 2000.

The Russell 2000 holds particular significance because small companies within it often provide a more accurate reflection of the country's economic health.

These businesses focus on internal and domestic operations, primarily within the US.

To be included in the Russell 2000, companies must meet three requirements:

  • Size: The market capitalization of the company seeking entry must exceed $30 million.
  • Liquidity: The company must have a daily average trading volume of at least $130,000.
  • Float: The float, representing the available outstanding shares for purchase, must be greater than 5% of the total shares in the market.

Small market capitalization companies, commonly referred to as small caps, fall within the $300 million to $2 billion market cap range.

Those above $2 billion are considered medium caps, and the largest are known as large caps or big caps.

Investors interested in small-cap stocks can choose from various specialized vehicles, including mutual funds and ETFs.

But in this piece, we will take a look at five stocks within the Russell 2000 that are highly rated by the market, and we will utilize InvestingPro as our primary source of information.

1. Karyopharm Therapeutics

Karyopharm Therapeutics (NASDAQ:KPTI) is a pharmaceutical company that develops and markets drugs aimed at treating cancer and other diseases.

The company was incorporated in 2008 and is headquartered in Newton, Massachusetts.

Karyopharm Therapeutics Stock Chart
Karyopharm Therapeutics Stock Chart

It reports quarterly results on February 15. Looking ahead to 2024 the forecast is for earnings per share (EPS) to increase +6.6%, with the increase being +19.3% by 2025.

Karyopharm Therapeutics Analyst Estimates
Karyopharm Therapeutics Analyst Estimates

Source: InvestingPro

Its shares closed the week at $1.04. The potential the market gives it is tremendous, at no less than around $6.

Karyopharm Therapeutics Targets
Karyopharm Therapeutics Targets

Source: InvestingPro

2. Rallybio

Rallybio (NASDAQ:RLYB) is a biotech company that is dedicated to developing life-transforming therapies for patients suffering from serious and rare diseases. It was founded in 2018 and is based in New Haven, Connecticut.

Rallybio Stock Chart
Rallybio Stock Chart

On March 12, we will know its accounts for the quarter. The forecast is that in the computation of 2023, it will have increased its earnings per share (EPS) by +13.4%.

Rallybio Forecasts
Rallybio Forecasts

Source: InvestingPro

In 2023 some of their research passed phase 1 and now in 2024, they expect everything to go well and achieve important milestones.

Its shares closed the week at $1.31. The potential the market gives it is stratospheric at $13.80.

Rallybio Targets
Rallybio Targets

Source: InvestingPro

3. Vor Biopharma

Vor Biopharma (NASDAQ:VOR) is engaged in the development of engineered stem cell therapies for cancer patients. The company was formed in 2015 and is based in Cambridge, Massachusetts.

Vor Biopharma Stock Chart
Vor Biopharma Stock Chart

It will release its numbers for the quarter on March 21 and is expected to increase earnings per share (EPS) by +15.74% and end 2023 on its computation with an increase of +20.9%.

Vor Biopharma Forecasts
Vor Biopharma Forecasts

Source: InvestingPro

Its shares closed the week at $2.22. The potential given by the market stands at $15.07.

Vor Biopharma Targets
Vor Biopharma Targets

Source: InvestingPro

4. Tenaya Therapeutics

Tenaya Therapeutics (NASDAQ:TNYA) is a biotechnology company that develops and offers therapies for heart disease. It was incorporated in 2016 and is headquartered in South San Francisco, California.

Tenaya Therapeutics Stock Chart
Tenaya Therapeutics Stock Chart

On March 20 turn for quarter accounts with a forecast of an earnings per share (EPS) increase of +49.59%.

Tenaya Therapeutics Upcoming Earnings
Tenaya Therapeutics Upcoming Earnings

Source: InvestingPro

It presents 7 ratings, of which all are buy.

Its shares closed the week at $4.55. The potential given by the market stands at $19.14.

Tenaya Therapeutics Targets
Tenaya Therapeutics Targets

Source: InvestingPro

5. Compass Therapeutics

Compass Therapeutics (NASDAQ:CMPX) is a biopharmaceutical company engaged in the development of antibody-based therapeutics to treat various diseases. It was founded in 2014 and is based in Boston, Massachusetts.

Compass Therapeutics Stock Price Chart
Compass Therapeutics Stock Price Chart

On March 1, we will get the quarterly numbers, and they're expected to show an increase in earnings per share (EPS) of +37.14%.

Compass Therapeutics Upcoming Earnings
Compass Therapeutics Upcoming Earnings

Source: InvestingPro

Its shares closed the week at $1.22. The potential given by the market stands at $9.40.

Compass Therapeutics Targets
Compass Therapeutics Targets

Source: InvestingPro

***

Take your investing game to the next level in 2024 with ProPicks

Institutions and billionaire investors worldwide are already well ahead of the game when it comes to AI-powered investing, extensively using, customizing, and developing it to bulk up their returns and minimize losses.

Now, InvestingPro users can do just the same from the comfort of their own homes with our new flagship AI-powered stock-picking tool: ProPicks.

With our six strategies, including the flagship "Tech Titans," which outperformed the market by a lofty 1,183% over the last decade, investors have the best selection of stocks in the market at the tip of their fingers every month.

Subscribe here and never miss a bull market again!

Don't forget your free gift! Use coupon code UKTopDiscount at checkout for a 10% discount on the Pro yearly & bi-yearly plans.

Disclaimer: This article is written for informational purposes only; it does not constitute a solicitation, offer, advice, or recommendation to invest as such it is not intended to incentivize the purchase of assets in any way. I would like to remind you that any type of asset, is evaluated from multiple points of view and is highly risky and therefore, any investment decision and the associated risk remains with the investor.

5 Russell 2000 Stocks Poised to Give the Large Caps a Run for Their Money
 

Related Articles

Edison Group
1Spatial: Landmark 1Streetworks Contract By Edison Group - Feb 22, 2024

SPA has announced that following a successful trial, UK Power Networks has signed a contract to deploy 1Streetworks, 1Spatial PLC (LON:SPA)’s traffic plan automation application....

5 Russell 2000 Stocks Poised to Give the Large Caps a Run for Their Money

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email